Montana Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• AHA Scientific Statement Update on Kawasaki Disease: Identifying and Managing Patients at High Risk
  There have been significant advances in the understanding of Kawasaki disease (KD) since the first published report in 1967. The recently published 2024 American Heart Association scientific statement reviews the latest evidence and expert consensus since the prior version in 2017...
• FDA Update: Abbott Removes HeartMate Mobile Power Unit
  The U.S. Food and Drug Administration (FDA) announced on April 24 that Abbott has removed the HeartMate Mobile Power Unit, used with HeartMate II and HeartMate 3 Left Ventricular Assist Systems, due to reports of sudden, unexpected power loss.
• FINEARTS-HF: Finerenone Improves Outcomes Regardless of Baseline Kidney Risk
  Finerenone was found to consistently improve clinical outcomes as well as heart failure (HF)-related health status and albuminuria, in patients with HF with mildly reduced ejection fraction (HFmrEF) or HF with preserved ejection fraction (HFpEF) regardless of baseline kidney risk...
• DCD Heart Transplantation With taNRP vs. DPP: Outcomes at 1 Year
  Donation after circulatory determination of death (DCD) heart transplant recipients with hearts retrieved via thoraco-abdominal normothermic regional perfusion (taNRP) were less likely to have severe primary graft dysfunction (PGD)...
• Omny-IRE: Novel OMNYPULSE Catheter Effective, Safe in Treatment of Paroxysmal AFib
  The OMNYPULSE pulsed field ablation (PFA) catheter had a 100% acute success rate, paired with a strong safety profile, in treating paroxysmal atrial fibrillation (AFib), according to the three-month results of the Omny-IRE trial presented as a late-breaking trial...